Corealis Pharma and PhinC Group Collaborate to Bring Predictive Modeling into Early Formulation Development
Combining formulation expertise and predictive modeling to make smarter development decisions earlier and reduce clinical development risk. LAVAL, Quebec — Corealis Pharma (“Corealis”) and PhinC Group (“PhinC”) have announced a strategic collaboration to integrate physiologically based biopharmaceutics modeling (PBBM) and physiologically based pharmacokinetic (PBPK) modeling directly into oral…
We haven't written up this one. Financial Post has the full story — the link below goes straight to it.
